Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001766291-19-000001
Filing Date
2019-02-15
Accepted
2019-02-15 16:30:20
Documents
1
Effectiveness Date
2019-02-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7308
  Complete submission text file 0001766291-19-000001.txt   8347
Mailing Address 8 ST. MARY'S STREET #614 BOSTON MA 02215
Business Address 8 ST. MARY'S STREET #614 BOSTON MA 02215 781-954-0250
Leuko Labs, Inc. (Filer) CIK: 0001766291 (see all company filings)

EIN.: 822401961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-333009 | Film No.: 19611895